Home > Specialties > Radiofrequency Therapy Systems, Tissue Ablation, Cardiac

Radiofrequency Therapy Systems, Tissue Ablation, Cardiac

Definition : Tissue ablation radiofrequency therapy systems designed to ablate (i.e., produce a therapeutic lesion) regions of endocardial tissue that give rise to or support cardiac arrhythmia. These systems typically consist of a radiofrequency generator (frequencies below 500 kHz are usual), a multipolar catheter 2 to 4 mm long with distal surface or needle-like electrodes, and a neutral electrode that is placed on the body surface. Some systems include thermocouples at the tip of the electrodes for temperature-controlled mode capability.

Entry Terms : "Cardiac Ablation Systems"

UMDC code : 18608

U.S.companies only
Suppress Subsidiary Companies

1-4 of 4 Match(es).

AtriCure Inc

Company Type: Parent

AtriCure, Inc. is a leading company developing, manufacturing and selling innovative surgical ablation systems designed to create precise lesions, or scars, in tissue.

Boston Scientific Corp

Company Type: Parent

In 1969, fascinated by the possibility of bringing pioneering medical devices and treatments to patients across the world, John Abele joined Medi-Tech, a company that was developing alternatives to traditional surgery. Pete Nicholas was looking for an investment, and when he met John, the pieces came together.

Medtronic Inc

Company Type: Parent

At Medtronic, we're changing the face of chronic disease. By working closely with physicians around the world, we create therapies to help patients do things they never thought possible.

nContact Surgical Inc

Company Type: Parent

nContact was started because catheter and surgical ablation companies had not solved two technical issues: the ability to consistently create visible linear lesions that could be connected into a comprehensive lesion pattern, and the ability to position and ablate on the posterior of the atrium under direct endoscopic visibility.

1-4 of 4 Match(es).